Immuneering (IMRX) Shares Outstanding (Weighted Average): 2020-2024
Historic Shares Outstanding (Weighted Average) for Immuneering (IMRX) over the last 4 years, with Dec 2024 value amounting to $31.1 million.
- Immuneering's Shares Outstanding (Weighted Average) rose 6.09% to $31.1 million in Q4 2024 from the same period last year, while for Sep 2024 it was $29.7 million, marking a year-over-year increase of 1.33%. This contributed to the annual value of $31.1 million for FY2024, which is 6.09% up from last year.
- Immuneering's Shares Outstanding (Weighted Average) amounted to $31.1 million in Q4 2024, which was up 4.71% from $29.7 million recorded in Q3 2024.
- Over the past 5 years, Immuneering's Shares Outstanding (Weighted Average) peaked at $31.1 million during Q4 2024, and registered a low of $23.9 million during Q4 2020.
- Its 3-year average for Shares Outstanding (Weighted Average) is $28.3 million, with a median of $29.3 million in 2023.
- Data for Immuneering's Shares Outstanding (Weighted Average) shows a peak YoY rose of 10.88% (in 2023) over the last 5 years.
- Immuneering's Shares Outstanding (Weighted Average) (Quarterly) stood at $23.9 million in 2020, then increased by 8.59% to $25.9 million in 2021, then increased by 1.79% to $26.4 million in 2022, then grew by 10.85% to $29.3 million in 2023, then grew by 6.09% to $31.1 million in 2024.
- Its last three reported values are $31.1 million in Q4 2024, $29.7 million for Q3 2024, and $29.7 million during Q2 2024.